NextCure picks up $93 mln Series B

Maryland-based NextCure Inc., a privately-held biopharmaceutical company, has raised $93 million in Series B financing. Hillhouse Capital Management and Quan Capital led the round with participation from other investors that included Bay City Capital, Surveyor Capital, Ping An Ventures, Taiho Ventures LLC, ArrowMark Partners, NS Investment, Canaan Partners, Lilly Asia Ventures, OrbiMed Advisors LLC, Pfizer Inc., Sofinnova Ventures and Alexandria Venture Investments. In conjunction with the financing, Michael Yi of Hillhouse and Dr. Stella Xu of Quan Capital will join NextCure’s board of directors.

Source: Press Release